1. "2023"
Formats
  1. Journal Article (2318)
  2. Meeting Abstract (1954)
  3. Review (629)
  4. Editorial (353)
  5. Book Section (144)
  6. Research Letter (101)
  7. Guidelines (97)
  8. Correspondence (91)
  9. Miscellaneous (57)
  10. Conference Paper (50)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1380)
  3. Sloan Kettering Institute Postdocs (1151)
  4. Hematologic Malignancies, Division of (1038)
  5. GSK Faculty (1016)
  6. Surgery (930)

More Groups

People
  1. Saad Usmani (123)
  2. Sergio Giralt (104)
  3. Miguel-Angel Perales (101)
  4. Gilles Salles (97)
  5. Gunjan Shah (85)
  6. Michael Scordo (81)

More People

Years
  1. 2023 (5804)
Publications
  1. Journal of Clinical Oncology (553)
  2. Blood (402)
  3. Annals of Oncology (154)
  4. Annals of Surgical Oncology (120)
  5. International Journal of Radiation Oncology, Biology, Physics (116)
  6. Laboratory Investigation (88)

More Publications

Publishers
  1. Elsevier Inc. (762)
  2. American Society of Clinical Oncology (606)
  3. American Society of Hematology (478)
  4. Springer (375)
  5. Oxford University Press (359)
  6. Nature Publishing Group (339)

More Publishers

Results (5804)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation
    Review

    O’Reilly, R. J.; Prockop, S.; Oved, J. H.
    Frontiers in Immunology (2023)

    Fulltext@MSK | Save
  • 3D Printing in a hospital: Centralized clinical implementation and applications for comprehensive care
    Review

    Hellman, S.; Frisch, P.; Platzman, A.; Booth, P.
    Digital Health (2023)

    Fulltext@MSK | Save
  • The LASRE trial: Further support for laparoscopic total mesorectal excision?
    Editorial

    Narasimhan, V.; Smith, J. J.
    Chinese Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Novel therapeutics in ovarian cancer: Expanding the toolbox
    Review

    Moufarrij, S.; O'Cearbhaill, R. E.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting
    Journal Article

    Outhwaite, I. R.; Singh, S.; Berger, B. T.; Knapp, S.; Chodera, J. D.; Seeliger, M. A.
    eLife (2023)

    Fulltext@MSK | Save
  • Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
    Journal Article

    Hinterleitner, M.; Pfeiffer, R.; Trautwein, N. F.; Sipos, B.; Singer, S.; Nadalin, S.; Königsrainer, A.; Lauer, U. M.; la Fougère, C.; Zender, L.; more...
    Frontiers in Endocrinology (2023)

    Fulltext@MSK | Save
  • Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
    Journal Article

    Marra, A.; Trapani, D.; Ferraro, E.; Curigliano, G.
    Cancer Treatment and Research (2023)

    Fulltext@MSK | Save
  • Innovative therapeutic approaches for patients with HER2-positive breast cancer
    Journal Article

    Taurelli Salimbeni, B.; Ferraro, E.; Boscolo Bielo, L.; Curigliano, G.
    Cancer Treatment and Research (2023)

    Fulltext@MSK | Save
  • Breast cancer brain metastases: Achilles’ heel in breast cancer patients’ care
    Journal Article

    Ferraro, E.; Seidman, A. D.
    Cancer Treatment and Research (2023)

    Fulltext@MSK | Save
  • Estimating the benefit of preoperative systemic therapy to reduce the extent of breast cancer surgery: Current standard and future directions
    Journal Article

    Montagna, G.
    Cancer Treatment and Research (2023)

    Fulltext@MSK | Save